{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:19:50Z","timestamp":1782915590793,"version":"3.54.5"},"reference-count":17,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"bioMerieux, Inc.","award":["Vitek 2 CZA clinical trial"],"award-info":[{"award-number":["Vitek 2 CZA clinical trial"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,2,18]]},"abstract":"<jats:p>\n            In this multisite study, Vitek 2 AST-Gram-Negative Ceftazidime\/Avibactam test results for 1,073 isolates (866\n            <jats:italic>Enterobacterales<\/jats:italic>\n            and 207\n            <jats:named-content content-type=\"genus-species\">Pseudomonas aeruginosa<\/jats:named-content>\n            ) were compared to the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BMD) reference method. The results were analyzed for essential agreement (EA), category agreement (CA), major error rates, and very major error rates following FDA\/ISO performance criteria using the FDA-recognized CLSI\/EUCAST breakpoints (sensitive [S], \u22648\/4\u2009\u03bcg\/ml; resistant [R], \u226516\/4\u2009\u03bcg\/ml).\n          <\/jats:p>","DOI":"10.1128\/jcm.01870-20","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T14:29:56Z","timestamp":1606832996000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Multicenter Evaluation of Ceftazidime-Avibactam Susceptibility Testing of\n            <i>Enterobacterales<\/i>\n            and Pseudomonas aeruginosa on the Vitek 2 System"],"prefix":"10.1128","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6568-156X","authenticated-orcid":true,"given":"Romney","family":"Humphries","sequence":"first","affiliation":[{"name":"UCLA Health System, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Campeau","sequence":"additional","affiliation":[{"name":"UCLA Health System, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Davis","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Nagaro","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent J.","family":"LaBombardi","sequence":"additional","affiliation":[{"name":"NewYork-Presbyterian Queens, Flushing, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Franklin","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, Inc., Hazelwood, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Heimbach","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, Inc., Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5373-3361","authenticated-orcid":true,"given":"Hari P.","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, Inc., Hazelwood, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.01.018"},{"key":"e_1_3_3_3_2","volume-title":"Antibiotic resistance threats in the United States, 2019","author":"CDC","year":"2019","unstructured":"CDC. 2019. Antibiotic resistance threats in the United States, 2019. CDC, Atlanta, GA."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0902-x"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks523"},{"key":"e_1_3_3_6_2","unstructured":"National Institutes of Health US National Library of Medicine. 2019. AVYCAZ- ceftazidime avibactam powder for solution. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.05.003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-019-1613-5"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01093-17"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.114911"},{"key":"e_1_3_3_11_2","unstructured":"Franklin S Dwivedi HP LaBombardi  V Davis  T Humphries R Hindler J Campeau S Deol P. 2018. ASM Microbe poster 232."},{"key":"e_1_3_3_12_2","volume-title":"M100: performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. M100: performance standards for antimicrobial susceptibility testing, 28th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"28"},{"key":"e_1_3_3_13_2","volume-title":"Guidance for industry and FDA\u2013class II special controls document: antimicrobial susceptibility test (AST) systems","author":"US Food and Drug Administration","year":"2007","unstructured":"US Food and Drug Administration. 2007. Guidance for industry and FDA\u2013class II special controls document: antimicrobial susceptibility test (AST) systems. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Washington, DC."},{"key":"e_1_3_3_14_2","unstructured":"ISO\/FDIS. 2007. ISO\/FDIS 20776\u20132:2007: clinical laboratory testing and in vitro diagnostic test systems\u2014susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 2: evaluation of performance of antimicrobial susceptibility test devices. ISO Geneva Switzerland."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw602"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00021-15"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/647952"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(83)90028-7"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01870-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01870-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:54:23Z","timestamp":1646477663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01870-20"}},"subtitle":[],"editor":[{"given":"Patricia J.","family":"Simner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,18]]}},"alternative-id":["10.1128\/JCM.01870-20"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01870-20","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"2020-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01870-20"}}